Testing aticaprant with antipsychotic medication for schizophrenia
Part of Mental health clinical trials.
This study tests whether a new medication called aticaprant is safe and well-tolerated when added to your current antipsychotic medication for schizophrenia. The goal is to see if it could help improve symptoms without causing serious side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with schizophrenia (confirmed by a clinical interview)
- You are currently taking exactly one antipsychotic medication at a stable dose
- You receive outpatient psychiatric care at the time of screening
- You have not had major changes to antidepressant or anti-anxiety medication in the past 8 weeks
- You do not have a history of severe substance use or heavy cannabis use in the past month
- You do not have a history of serious stomach ulcers or bleeding, or untreated stomach infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, NBI-1117568, to see if it can help prevent a relapse of schizophrenia symptoms. It is for adults who have been stable on other antipsychotics and want to avoid returning to the hospital for a psychiatric stay.
This trial tests whether cariprazine works and is safe for teens aged 13 to 17 with schizophrenia. It may help if your symptoms are still moderate to severe despite current care.
This trial tests an investigational medication called VV119 for adults experiencing a sudden worsening of schizophrenia symptoms. It aims to see if the drug is safe and effective in reducing symptoms like delusions, hallucinations, and disorganized thinking.
This trial tests a combination of an NMDA-targeting medicine and an anti-inflammatory treatment for people with schizophrenia that has not responded well to several standard treatments, including clozapine. If you qualify, the goal is to see whether this combination improves symptoms more than usual care.
This study tests a new medicine, KR23248, in healthy people to see if it is safe and how the body handles it. It is a first-in-human trial, so the main goal is to find out about side effects and how the drug moves through the body.
This study tests an experimental medication (NBI-1117570) for adults with schizophrenia who are currently in the hospital because of a sudden worsening of symptoms. The goal is to see if this new treatment can help control symptoms better.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.